Disposable Medical Biosensor Monitors Patients Remotely
|
By HospiMedica International staff writers Posted on 28 Jul 2020 |

Image: The LifeSignals LP1250 Remote Monitoring Patch Platform (Photo courtesy of LifeSignals)
A single-use two channel electrocardiogram (ECG) and heart rate biosensor provides up to three days of patient monitoring with remote data access.
The LifeSignals (Fremont, CA, USA) LP1250 Remote Monitoring Patch Platform is a wireless system designed for the continuous collection and monitoring of cardiac data in ambulatory, hospital, home, and healthcare settings. The data is transmitted wirelessly from the LP1250 to a remote secure server for storage and analysis. The monitoring patch can be integrated into clinical workflows, including remote patient monitoring systems, mobile cardiac telemetry systems, and Holter and event monitoring systems.
Features include a proprietary single-chip (LC1100) processor platform that allows secure capture, storage, and transmission of patient data, even in multi-patient hospital environments that produce multiple interferences; up to 72-hour data capture of both two-channel ECG and heart rate data; and a lightweight and splash-proof profile that improve patient comfort and compliance. The LP1250 will be sold worldwide by LifeSignals as a white-labeled device through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities.
“Healthcare professionals can remotely access patient data via third-party software for the screening and monitoring of common cardiac arrhythmias such atrial fibrillation, enabling rapid treatment decisions, independent of patient location,” said Surendar Magar, co-founder and CEO of LifeSignals. “The interoperable biosensor gives partners access to a ready-to-integrate, multi-parameter medical wearable with a straightforward ecosystem for fast on-boarding.”
Related Links:
LifeSignals
The LifeSignals (Fremont, CA, USA) LP1250 Remote Monitoring Patch Platform is a wireless system designed for the continuous collection and monitoring of cardiac data in ambulatory, hospital, home, and healthcare settings. The data is transmitted wirelessly from the LP1250 to a remote secure server for storage and analysis. The monitoring patch can be integrated into clinical workflows, including remote patient monitoring systems, mobile cardiac telemetry systems, and Holter and event monitoring systems.
Features include a proprietary single-chip (LC1100) processor platform that allows secure capture, storage, and transmission of patient data, even in multi-patient hospital environments that produce multiple interferences; up to 72-hour data capture of both two-channel ECG and heart rate data; and a lightweight and splash-proof profile that improve patient comfort and compliance. The LP1250 will be sold worldwide by LifeSignals as a white-labeled device through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities.
“Healthcare professionals can remotely access patient data via third-party software for the screening and monitoring of common cardiac arrhythmias such atrial fibrillation, enabling rapid treatment decisions, independent of patient location,” said Surendar Magar, co-founder and CEO of LifeSignals. “The interoperable biosensor gives partners access to a ready-to-integrate, multi-parameter medical wearable with a straightforward ecosystem for fast on-boarding.”
Related Links:
LifeSignals
Latest Critical Care News
- AI Helps Optimize Therapy Selection and Dosing for Septic Shock
- Glowing Bacteria ‘Pills’ for Detecting Gut Diseases Could Eliminate Colonoscopies
- Skin-Permeable Polymer Patch Delivers Insulin Non-Invasively Through Skin
- Nanogel Technology Almost 100% Effective in Destroying Drug-Resistant Bacteria Within Hours
- Wearable Ultrasound Sensor Delivers Noninvasive Treatment Without Surgery
- Gel-Free ECG System to Transform Heart Health Diagnosis
- Biodegradable Patch Repairs Damaged Tissue After Heart Attack
- Magnetically Guided Microrobots to Enable Targeted Drug Delivery

- Smart Nanomaterials Detect and Treat Traumatic Brain Injuries Simultaneously
- Earlier Blood Transfusion Could Reduce Heart Failure and Arrhythmia in Heart Disease Patients
- 'Smart' Shirt Detects Epileptic Seizures in Real Time
- Skin Patch Measures Effectiveness of Flu/COVID Vaccines in 10 Minutes
- Complete Revascularization Reduces Risk of Death from Cardiovascular Causes
- Tiny Fish-Inspired Robots Navigate Through Body to Deliver Targeted Drug Therapy
- Coronary Artery Stenosis Could Protect Patients from Pulmonary Embolism Effects
- Sweat-Powered Sticker Turns Drinking Cup into Health Sensor
Channels
Surgical Techniques
view channelNovel Endoscopy Technique Provides Access to Deep Lung Tumors
Detecting lung cancer early can save lives, but diagnosing small tumors deep in the outer regions of the lungs remains a major clinical challenge. Although CT scans frequently identify tiny suspicious... Read more
New Study Findings Could Halve Number of Stent Procedures
When a coronary artery becomes acutely blocked during a heart attack, opening it immediately is essential to prevent irreversible damage. However, many patients also have other narrowed vessels that appear... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







